Category: Mortality & Morbidity

Posted on | Posted on John Murphy | Leave a Comment on C-Reactive Protein Level May Predict the Risk of COVID-19 Aggravation

C-Reactive Protein Level May Predict the Risk of COVID-19 Aggravation

Authors: Guyi Wang 1, Chenfang Wu 1, Quan Zhang 2, Fang Wu 3, Bo Yu 1, Jianlei Lv 2, Yiming Li 4, Tiao Li 5, Siye Zhang 1, Chao Wu 6 7 8, Guobao Wu 1, Yanjun Zhong 1Affiliations expand Abstract Background: Clinical findings indicated that a fraction of coronavirus disease 2019 (COVID-19) patients diagnosed as mild…[...]

Read More
Posted on | Posted on John Murphy | Leave a Comment on Elevated level of C‐reactive protein may be an early marker to predict risk for severity of COVID‐19

Elevated level of C‐reactive protein may be an early marker to predict risk for severity of COVID‐19

Authors: Nurshad Ali 1 The outbreak of coronavirus disease‐2019 (COVID‐19) is an emerging global health threat. The healthcare workers are facing challenges in reducing the severity and mortality of COVID‐19 across…[...]

Read More
Posted on | Posted on John Murphy | Leave a Comment on The role of C-reactive protein as a prognostic marker in COVID-19

The role of C-reactive protein as a prognostic marker in COVID-19

Authors: Dominic Stringer,1Philip Braude,2Phyo K Myint,3Louis Evans,4Jemima T Collins,5Alessia Verduri,6Terry J Quinn,7Arturo Vilches-Moraga,8Michael J Stechman,9Lyndsay Pearce,10Susan Moug,11Kathryn McCarthy,12Jonathan Hewitt,13 and Ben Carter1 Abstract Background C-reactive protein (CRP) is a non-specific acute phase…[...]

Read More
Posted on | Posted on John Murphy | Leave a Comment on Body mass index and severity/fatality from coronavirus disease 2019: A nationwide epidemiological study in Korea

Body mass index and severity/fatality from coronavirus disease 2019: A nationwide epidemiological study in Korea

Authors: In Sook Kang , Kyoung Ae Kong Published: June 22, 2021 Abstract Obesity has been reported as a risk factor for severe coronavirus disease 2019 (COVID-19) in recent studies. However,…[...]

Read More
Posted on | Posted on John Murphy | Leave a Comment on Lack of antibodies against seasonal coronavirus OC43 nucleocapsid protein identifies patients at risk of critical COVID-19

Lack of antibodies against seasonal coronavirus OC43 nucleocapsid protein identifies patients at risk of critical COVID-19

Authors: MartinDugasa1TanjaGrote-Westrickb1UtaMerledMichaelaFontenaylmAndreas E.KremerhFrankHansesijRichardVollenbergcEvaLorentzenbShilpaTiwari-BecklerdJérômeDucheminlSyrineEllouzelMarcelVetterhJuliaFürsthPhilippSchusterkTobiasBrixaClaudia M.DenkingerfgCarstenMüller-TidoweHartmutSchmidtc…JoachimKühnb1 Highlights Does prior infection with seasonal human coronavirus OC43 protect against critical COVID-19?• Findings: In an international multi-center study inpatients without anti-HCoV OC43 NP antibodies had an increased risk of…[...]

Read More
Posted on | Posted on John Murphy | Leave a Comment on Lack of antibodies against seasonal coronavirus OC43 nucleocapsid protein identifies patients at risk of critical COVID-19

Lack of antibodies against seasonal coronavirus OC43 nucleocapsid protein identifies patients at risk of critical COVID-19

Authors: Martin Dugas 1, Tanja Grote-Westrick 2, Uta Merle 3, Michaela Fontenay 4, Andreas E Kremer 5, Frank Hanses 6, Richard Vollenberg 7, Eva Lorentzen 8, Shilpa Tiwari-Heckler 9, Jérôme Duchemin 10, Syrine Ellouze 11, Marcel Vetter 12, Julia Fürst 13, Philipp Schuster 14, Tobias Brix 15, Claudia M Denkinger 16, Carsten Müller-Tidow 17, Hartmut Schmidt 18, Phil-Robin Tepasse 19, Joachim Kühn 20 Abstract Background: The vast majority of COVID-19…[...]

Read More
Posted on | Posted on John Murphy | Leave a Comment on Underlying Medical Conditions and Severe Illness Among 540,667 Adults Hospitalized With COVID-19, March 2020–March 2021

Underlying Medical Conditions and Severe Illness Among 540,667 Adults Hospitalized With COVID-19, March 2020–March 2021

Authors: Lyudmyla Kompaniyets, PhD1; Audrey F. Pennington, PhD1; Alyson B. Goodman, MD1,2; Hannah G. Rosenblum, MD1,3; Brook Belay, MD1; Jean Y. Ko, PhD1,2; Jennifer R. Chevinsky, MD1,3; Lyna Z. Schieber,…[...]

Read More